Craneware plc (CRW.L)
- Previous Close
2,230.00 - Open
2,230.00 - Bid --
- Ask --
- Day's Range
2,175.00 - 2,275.00 - 52 Week Range
1,142.00 - 2,275.00 - Volume
48,593 - Avg. Volume
124,855 - Market Cap (intraday)
798.476M - Beta (5Y Monthly) 0.13
- PE Ratio (TTM)
107.62 - EPS (TTM)
0.21 - Earnings Date Mar 4, 2024
- Forward Dividend & Yield 0.29 (1.30%)
- Ex-Dividend Date Mar 21, 2024
- 1y Target Est
27.26
Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Trisus pricing transparency software; Trisus Pricing Analyzer, a solution that simplifies and automates the price modeling process; Trisus Chargemaster, an automated chargemaster management solution; InSight Medical Necessity, a solution that offers medical necessity for the United States payors; Trisus Claims Informatics, a retrospective charge capture analytical application that identifies areas of risk for its team to investigate; Trisus Supply, a solution that improves supplies reimbursement; and InSight Audit, an audit management solution for government and commercial payors. It also offers Trisus Decision Support; Trisus Labor Productivity; Trisus Medication Analytic solutions; and Trisus supplies assistant solutions. In addition, the company provides Sentinel, a drug tracking solution; Sentrex, a SaaS-based solution that helps covered entities expand medication access; Referral Verification System; and Central Pharmacy Distribution, a centralized purchasing application. Further, it offers appeal, professional, and pharmacy professional services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.
www.thecranewaregroup.com734
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: CRW.L
Performance Overview: CRW.L
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRW.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRW.L
Valuation Measures
Market Cap
787.88M
Enterprise Value
786.44M
Trailing P/E
103.92
Forward P/E
27.62
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.38
Price/Book (mrq)
3.00
Enterprise Value/Revenue
4.36
Enterprise Value/EBITDA
15.00
Financial Highlights
Profitability and Income Statement
Profit Margin
5.19%
Return on Assets (ttm)
2.08%
Return on Equity (ttm)
2.86%
Revenue (ttm)
180.56M
Net Income Avi to Common (ttm)
9.36M
Diluted EPS (ttm)
0.21
Balance Sheet and Cash Flow
Total Cash (mrq)
63.9M
Total Debt/Equity (mrq)
19.15%
Levered Free Cash Flow (ttm)
95.99M
Research Analysis: CRW.L
Company Insights: CRW.L
CRW.L does not have Company Insights